8,517 articles
David W. Eyre
David W. Eyre is an infectious diseases physician-scientist and Professor of Infectious Diseases at the University of Oxford, known for genomic studies of hospital outbreaks and COVID-19 transmission.
David W. Golde
David W. Golde (1940–2004) was an American hematologist and oncologist whose laboratory purified human GM-CSF and derived the KG-1 leukemia cell line, later serving as Physician-in-Chief at Memorial Sloan-Kettering.
David W. Kimberlin
David W. Kimberlin is an American pediatric infectious diseases researcher at the University of Alabama at Birmingham, leading the NIH-funded Collaborative Antiviral Study Group and editing the 2021 Red Book.
David W. Russell
David W. Russell is an American molecular geneticist at UT Southwestern Medical Center in Dallas who defined the pathways by which the body breaks down cholesterol into bile acids and steroid hormones.
David W. Talmage
David W. Talmage (1919–2014) was an American immunologist and distinguished professor at the University of Colorado, known for conceiving the clonal selection theory of antibody formation.
David Wade Clapp
David Wade Clapp is an American neonatologist and physician-scientist who chairs Pediatrics at Indiana University, leads Riley Hospital for Children, and was elected to the National Academy of Medicine in 2020.
David Weatherall
Sir David Weatherall (1933–2018) was a British haematologist who showed that thalassaemia results from imbalanced globin chain synthesis, founded Oxford's Weatherall Institute of Molecular Medicine, and was knighted in 1987.
David Werring
David J. Werring is a British neurologist and Professor of Clinical Neurology at UCL Queen Square Institute of Neurology, known for research on cerebral microbleeds and intracerebral hemorrhage.
David Weyhe Smith
David Weyhe Smith (1926–1981) was an American pediatrician at the University of Washington who founded dysmorphology, the study of congenital malformation patterns, and co-described fetal alcohol syndrome in 1973.
David Y. Mason
David Y. Mason (1941–2008) was a British immunopathologist and hematologist at Oxford's John Radcliffe Hospital whose 1983 study established monoclonal-antibody staining as a reliable test for lymphoma.
David Yi‐Yung Hsia
David Yi-Yung Hsia (1925–1972) was an American pediatrician and biochemical geneticist, born in Shanghai, who developed the phenylalanine tolerance test and newborn blood screening for phenylketonuria and studied galactosemia.
David Z.I. Cherney
David Z.I. Cherney (David Zev Isaac Cherney) is a Canadian nephrologist and University of Toronto professor who directs the Renal Physiology Laboratory and studies SGLT2 inhibitors in diabetic kidney disease.
Davide F. Robbiani
Davide F. Robbiani is a Swiss immunologist who directs the Institute for Research in Biomedicine in Bellinzona and is a full professor at USI since 2020.
DavidJ.H. Brock
David J. H. Brock was a medical geneticist at the University of Edinburgh who built the biochemical and DNA-based methods used in antenatal diagnosis from the early 1970s to the late 1980s.
Dawn L. Hershman
Dawn L. Hershman, also published as Dawn Hershman, is an American medical oncologist at Columbia University who studies breast cancer treatment and why patients stop taking cancer therapies.
Dayu Lin
Dayu Lin is a neuroscientist at NYU Grossman School of Medicine who identified an aggression locus in the mouse hypothalamus and studies the neural circuits of aggression, mating, and parenting.
Dean Burk
Dean Burk (1904–1988) was an American biochemist who co-authored the 1934 Lineweaver–Burk plot, one of biochemistry's most cited papers, and was Chief Chemist at the National Cancer Institute from 1958 to 1974.
Dean F. Bajorin
Dean F. Bajorin is an American medical oncologist at Memorial Sloan Kettering and Weill Cornell who developed bladder cancer chemotherapy regimens and led the CheckMate 274 immunotherapy trial.
Dean Fergusson
Dean A. Fergusson is a Canadian clinical epidemiologist and transfusion-medicine researcher at the Ottawa Hospital Research Institute who led the BART trial, which found aprotinin increased mortality in cardiac surgery.
Dean G. Tang
Dean G. Tang is a cancer researcher who studies cancer cell heterogeneity and prostate cancer stem cells, chairing Pharmacology & Therapeutics at Roswell Park in Buffalo, New York.
Dean H. Lockwood
Dean H. Lockwood (1937–2004) was an American physician-scientist in endocrinology who led the Endocrine and Metabolism Unit at the University of Rochester and warned of liquid protein diet dangers.
Dean Ho (nanomedicine researcher)
Dean Ho is a nanomedicine and digital medicine researcher who heads Biomedical Engineering at the National University of Singapore and is known for nanodiamond drug delivery and CURATE.AI.
Dean J. Kereiakes
Dean J. Kereiakes, also known as Dean Kereiakes, is an American interventional cardiologist who chairs The Christ Hospital Heart and Vascular Institute in Cincinnati, Ohio.
Dean M. Wingerchuk
Dean M. Wingerchuk is a neurologist and Chair of Neurology at Mayo Clinic in Arizona, known for the diagnostic criteria that defined NMOSD as distinct from multiple sclerosis.
Dean Sheppard
Dean Sheppard is an American physician-scientist and UCSF professor of medicine whose laboratory showed that integrins such as αvβ6 activate latent TGF-β, driving pulmonary fibrosis.
Dean T. Jamison
Dean T. Jamison, also known as Dean Jamison, is an American health economist who led the World Bank's 1993 World Development Report, Investing in Health, and the Disease Control Priorities project.
Dean T. Mason
Dean T. Mason is an American cardiologist who founded the Division of Cardiovascular Medicine at UC Davis in 1968 and served as president of the American College of Cardiology.
Dean Y. Li
Dean Y. Li is an American cardiologist and vascular biologist who leads Merck Research Laboratories, after two decades at the University of Utah studying blood vessel stability.
Deane F. Mosher
Deane F. Mosher is a professor of biomolecular chemistry and Medicine at the University of Wisconsin–Madison whose laboratory studies fibronectin, thrombospondins, and vitronectin in blood plasma and platelets.
Deanna L. Kroetz
Deanna L. Kroetz is an American pharmacogenomicist and dean of the College of Pharmacy at The Ohio State University, elected to the National Academy of Medicine in 2025.